Zymeworks Common Stock Stock Technical Analysis
| ZYME Stock | USD 22.72 0.60 2.57% |
As of the 23rd of February, Zymeworks Common maintains the Market Risk Adjusted Performance of (0.41), downside deviation of 2.9, and Mean Deviation of 2.51. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zymeworks Common Stock, as well as the relationship between them. Please check out Zymeworks Common Stock variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Zymeworks Common Stock is priced fairly, providing market reflects its latest price of 22.72 per share. Given that Zymeworks Common Stock has jensen alpha of 0.4532, we strongly advise you to confirm Zymeworks Common Stock's prevalent market performance to make sure the company can sustain itself at a future point.
Zymeworks Common Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zymeworks, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZymeworksZymeworks | Build AI portfolio with Zymeworks Stock |
Zymeworks Common Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 36.46 | Strong Buy | 10 | Odds |
Most Zymeworks analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Zymeworks stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Zymeworks Common Stock, talking to its executives and customers, or listening to Zymeworks conference calls.
Will Biotechnology sector continue expanding? Could Zymeworks diversify its offerings? Factors like these will boost the valuation of Zymeworks Common. Anticipated expansion of Zymeworks directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Zymeworks Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.726 | Return On Assets | Return On Equity |
Zymeworks Common Stock's market price often diverges from its book value, the accounting figure shown on Zymeworks's balance sheet. Smart investors calculate Zymeworks Common's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Zymeworks Common's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zymeworks Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zymeworks Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zymeworks Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zymeworks Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zymeworks Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zymeworks Common.
| 11/25/2025 |
| 02/23/2026 |
If you would invest 0.00 in Zymeworks Common on November 25, 2025 and sell it all today you would earn a total of 0.00 from holding Zymeworks Common Stock or generate 0.0% return on investment in Zymeworks Common over 90 days. Zymeworks Common is related to or competes with Maze Therapeutics, Ardelyx, Spyre Therapeutics, Pharvaris, Intellia Therapeutics, BioCryst Pharmaceuticals, and Immunome. Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for ... More
Zymeworks Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zymeworks Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zymeworks Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.9 | |||
| Information Ratio | 0.0714 | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 4.46 |
Zymeworks Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zymeworks Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zymeworks Common's standard deviation. In reality, there are many statistical measures that can use Zymeworks Common historical prices to predict the future Zymeworks Common's volatility.| Risk Adjusted Performance | 0.0765 | |||
| Jensen Alpha | 0.4532 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1092 | |||
| Treynor Ratio | (0.42) |
Zymeworks Common February 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0765 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 2.51 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 2.9 | |||
| Coefficient Of Variation | 1116.89 | |||
| Standard Deviation | 4.44 | |||
| Variance | 19.72 | |||
| Information Ratio | 0.0714 | |||
| Jensen Alpha | 0.4532 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1092 | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 4.46 | |||
| Downside Variance | 8.43 | |||
| Semi Variance | 6.58 | |||
| Expected Short fall | (2.74) | |||
| Skewness | 4.11 | |||
| Kurtosis | 26.51 |
Zymeworks Common Stock Backtested Returns
Zymeworks Common Stock shows Sharpe Ratio of -0.0834, which attests that the company had a -0.0834 % return per unit of risk over the last 3 months. Zymeworks Common Stock exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zymeworks Common's Mean Deviation of 2.51, market risk adjusted performance of (0.41), and Downside Deviation of 2.9 to validate the risk estimate we provide. The firm maintains a market beta of -0.93, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Zymeworks Common are expected to decrease slowly. On the other hand, during market turmoil, Zymeworks Common is expected to outperform it slightly. At this point, Zymeworks Common Stock has a negative expected return of -0.21%. Please make sure to check out Zymeworks Common's skewness, and the relationship between the value at risk and day median price , to decide if Zymeworks Common Stock performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.01 |
Very weak reverse predictability
Zymeworks Common Stock has very weak reverse predictability. Overlapping area represents the amount of predictability between Zymeworks Common time series from 25th of November 2025 to 9th of January 2026 and 9th of January 2026 to 23rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zymeworks Common Stock price movement. The serial correlation of -0.01 indicates that just 1.0% of current Zymeworks Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.29 |
Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Zymeworks Common Stock Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Normalized Average True Range is used to analyze tradable apportunities for Zymeworks Common Stock across different markets.
About Zymeworks Common Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zymeworks Common Stock on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zymeworks Common Stock based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zymeworks Common Stock price pattern first instead of the macroeconomic environment surrounding Zymeworks Common Stock. By analyzing Zymeworks Common's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zymeworks Common's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zymeworks Common specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.39 | 0.24 | 0.22 | Revenue Per Share | 1.1 | 1.01 | 0.91 |
Zymeworks Common February 23, 2026 Technical Indicators
Most technical analysis of Zymeworks help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zymeworks from various momentum indicators to cycle indicators. When you analyze Zymeworks charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0765 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 2.51 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 2.9 | |||
| Coefficient Of Variation | 1116.89 | |||
| Standard Deviation | 4.44 | |||
| Variance | 19.72 | |||
| Information Ratio | 0.0714 | |||
| Jensen Alpha | 0.4532 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1092 | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 4.46 | |||
| Downside Variance | 8.43 | |||
| Semi Variance | 6.58 | |||
| Expected Short fall | (2.74) | |||
| Skewness | 4.11 | |||
| Kurtosis | 26.51 |
Zymeworks Common February 23, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Zymeworks stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.65) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 23.03 | ||
| Day Typical Price | 22.92 | ||
| Price Action Indicator | (0.61) | ||
| Market Facilitation Index | 0.93 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |